Rubia, Aninias S.
HRN: 16-79-93 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/10/2023
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
07/10/2023
07/10/2023
IVTT
4.5 G
Now
Cap; Sepsis
Waiting Final Action
Indication: Empiric Type of Infection: PneumoniaIntra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes